Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01585779 · ClinicalTrials.gov registry record
Contour 3D®/TriAd® Tricuspid Annuloplasty Ring Post-Market Clinical Trial
A clinical trial, sponsored by Medtronic Cardiovascular.
- Completed
- Registry status
- 64
- Enrollment target
NCT01585779 is a clinical trial that has completed, run by Medtronic Cardiovascular. The registered enrollment target is 64 participants.
The verdict
NCT01585779 has completed, sponsored by Medtronic Cardiovascular.
- COMPLETED
- Registry status
- 64 participants
- Enrollment target
Study Summary
The purpose of this study is to gather clinical information on the hemodynamic performance of the Contour 3D® and Tri-Ad® Tricuspid Annuloplasty Rings in a post-market environment.
Interventions
- DEVICE Contour 3D® implant for tricuspid valve repair
- DEVICE Tri-Ad® implant for tricuspid valve repair
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 64 participants |
| Start Date | 2012-05 |
| Est. Completion | 2016-06 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01585779
The ClinicalTrials.gov registry entry for NCT01585779 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 64 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medtronic Cardiovascular, which has 44 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Contour 3D® implant for tricuspid valve repair is the first listed.
NCT01585779 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01585779 about?
NCT01585779 is a clinical study titled "Contour 3D®/TriAd® Tricuspid Annuloplasty Ring Post-Market Clinical Trial". The purpose of this study is to gather clinical information on the hemodynamic performance of the Contour 3D® and Tri-Ad® Tricuspid Annuloplasty Rings in a post-market environment.
What is the current status of trial NCT01585779?
This trial is currently completed. The enrollment target is 64 participants. The study started on 2012-05. Estimated completion is 2016-06.
What interventions are being tested in trial NCT01585779?
The interventions under investigation include: Contour 3D® implant for tricuspid valve repair (DEVICE), Tri-Ad® implant for tricuspid valve repair (DEVICE).
Who is sponsoring clinical trial NCT01585779?
This trial is sponsored by Medtronic Cardiovascular, which has 44 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.